Cadrenal Therapeutics in Talks With Abbott to Study Tecarfarin in Patients With LVAD
Cadrenal Therapeutics in Talks With Abbott to Study Tecarfarin in Patients With LVAD
Cadrenal Therapeutics正在與Abbott商討在LVAD患者中研究Tecarfarin。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊